Etilevodopa
Etilevodopa[edit | edit source]
Etilevodopa is a pharmacological compound used in the treatment of Parkinson's disease, a chronic and progressive movement disorder. As a dopaminergic agent, Etilevodopa functions by being converted to dopamine in the brain, thus supplementing the decreased levels of this neurotransmitter typically seen in Parkinson's disease. It is chemically related to levodopa, being the ethyl ester derivative of this well-known medication.
Chemistry[edit | edit source]
Etilevodopa, chemically known as Ethyl-L-DOPA, is synthesized from levodopa by the introduction of an ethyl group to create an ester bond. This modification is intended to improve the pharmacokinetic properties of the drug, potentially allowing for better absorption and stability.
Mechanism of Action[edit | edit source]
The primary action of Etilevodopa is its conversion to dopamine once it crosses the blood-brain barrier. This conversion is facilitated by the enzyme Aromatic L-amino acid decarboxylase, which is present in the central nervous system. By increasing the levels of dopamine, Etilevodopa helps to alleviate the motor symptoms associated with Parkinson's disease such as tremors, stiffness, and bradykinesia.
Clinical Use[edit | edit source]
The use of Etilevodopa in clinical settings is aimed at managing the symptoms of Parkinson's disease. It may be used alone or in combination with other medications, such as Carbidopa, which inhibits the peripheral breakdown of levodopa, allowing more of it to reach the brain and reducing side effects.
Advantages[edit | edit source]
The ethyl ester form of levodopa is theorized to offer advantages over standard levodopa, including:
- Improved absorption from the gastrointestinal tract.
- Reduced dosage frequency due to extended duration of action.
- Potential reduction in the severity of side effects.
Side Effects[edit | edit source]
As with many medications, Etilevodopa may produce side effects, which can include, but are not limited to:
- Nausea and vomiting.
- Orthostatic hypotension (a drop in blood pressure when standing up).
- Dyskinesias (involuntary movements).
- Psychiatric symptoms such as hallucinations or depression.
Research and Development[edit | edit source]
Etilevodopa has undergone various stages of research and development. Clinical trials are essential to determine its efficacy and safety profile in comparison with standard levodopa or other Parkinson's disease treatments.
See Also[edit | edit source]
- Levodopa
- Carbidopa/Levodopa
- Parkinson's Disease Treatment
- Melevodopa, a similar dopaminergic agent with a methyl ester group.
- Dopamine Agonists, another class of drugs used to treat Parkinson's disease
References[edit | edit source]
 | This drug article relating to the nervous system is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
